INIGEM 23989
INSTITUTO DE INMUNOLOGIA, GENETICA Y METABOLISMO
Unidad Ejecutora - UE
congresos y reuniones científicas
Título:
Expression of interleukin 1 beta (IL-1β), in patients with type 2 diabetes (T2D) subject to protocols of metabolic compensation.
Autor/es:
CERRONE GE; BERGONZI F; LINARI MA; IGLESIAS MOLLI, AE; FRECHTEL GD; SPALVIERI M; MILLÁN, A
Lugar:
Buenos Aires
Reunión:
Congreso; Reunión Conjunta de Sociedades de Biociencias ? LXII Reunión Anual de la Sociedad Argentina de Investigación Clínica.; 2017
Resumen:
Abstract: We studied the expression of IL-1β, the genotype of a promoter SNP, and the relationship with biochemical-clinical variables; in individuals with DM2 undergoing metabolic compensation treatment. We studied 30 patients with metabolically decompensated DM2 (HbA1c> 8%), and after 6 and 12 months of compensatory treatment (HbA1c
